PULSE the living trend engine
↑ Rising Business

Hacking group claims major hack of Novo Nordisk and attempted $25 million extortion

Pharmaceutical giant Novo Nordisk faces a significant data breach involving patient clinical trial records and an attempted extortion.

9sources
10articles
8velocity
+168%since first seen
7h agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

Novo Nordisk has disclosed unauthorized access to its IT systems, leading to a breach involving clinical trial data. The hacking group identified as FulcrumSec has claimed responsibility for the incident, allegedly attempting to extort $25 million from the company.

Coverage from outlets including Reuters, SecurityWeek, and Scientific American emphasizes the potential exposure of sensitive research information. Additional reports from Yahoo Finance and Industrial Cyber highlight the breach alongside the company's existing challenges with GLP-1 supply strains and broader threats to pharmaceutical infrastructure.

Coverage does not yet specify the full scope of the affected clinical trial data or the company's response to the extortion demand. Future reports are expected to focus on the integrity of the compromised records and any potential operational impacts on the pharmaceutical manufacturer.

Synthesized by PULSE from the headlines below under a strict no-invention contract. Updated 3h ago.

Quick answers

Who has claimed responsibility for the breach?

The hacking group identified as FulcrumSec has claimed responsibility for the attack.

What data was exposed in the attack?

Coverage indicates that the breach resulted in the exposure of patient clinical trial data.

What is the status of the extortion demand?

Reports indicate that the hackers attempted to extort $25 million, though coverage does not specify the company's response.

Coverage (10)

Topics

Novo Nordisk FulcrumSec Cybersecurity Data Breach Pharmaceuticals

Related trends